Close



Oct 11, 2021 12:31PM
Oct 11, 2021 12:30PM
Sep 28, 2021 08:00AM
Sep 22, 2021 08:00AM
Sep 13, 2021 06:47AM
Sep 13, 2021 06:45AM
Sep 7, 2021 08:00AM Ocular Therapeutix™ to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
Aug 10, 2021 08:00AM
Aug 9, 2021 04:01PM
Aug 5, 2021 06:05PM
Aug 5, 2021 04:01PM
Jul 29, 2021 08:00AM
Jul 28, 2021 08:00AM
Jul 23, 2021 08:00AM Ocular Therapeutix (OCUL) Poised to Recover as Dextenza Grows 50% Sequentially - Piper Sandler
Jul 23, 2021 08:00AM
Jul 22, 2021 04:08PM
Jul 22, 2021 04:01PM
Jun 29, 2021 08:02AM
Jun 29, 2021 08:00AM
May 26, 2021 08:00AM
May 5, 2021 04:01PM Ocular Therapeutix™ Reports First Quarter 2021 Financial Results and Business Update
May 3, 2021 06:16PM
May 3, 2021 08:00AM
Apr 29, 2021 08:00AM
Apr 28, 2021 08:00AM
Mar 11, 2021 04:01PM
Mar 4, 2021 04:02PM
Mar 4, 2021 04:01PM Ocular Therapeutix™ Announces FDA Acceptance of Supplemental New Drug Application for DEXTENZA® (dexamethasone ophthalmic insert) for the Treatment of Ocular Itching Associated with Allergic Conjun
Mar 1, 2021 07:16AM
Mar 1, 2021 07:00AM
Feb 12, 2021 08:00AM
Feb 4, 2021 04:01PM
Jan 20, 2021 08:01AM
Jan 20, 2021 08:00AM
Jan 7, 2021 08:00AM Ocular Therapeutix™ Promotes Michael Goldstein, MD, MBA, to President, Ophthalmology and Appoints Rabia Gurses Ozden, MD as Senior Vice President, Clinical Development
Dec 22, 2020 08:46AM
Dec 22, 2020 08:45AM
May 10, 2019 07:30AM
Apr 2, 2019 08:16AM
Apr 2, 2019 08:15AM
Dec 3, 2018 09:42AM
Dec 3, 2018 07:01AM Ocular Therapeutix (OCUL) Announces FDA Approval of DEXTENZA for Treatment of Ocular Pain
Dec 3, 2018 07:00AM
Nov 7, 2018 04:01PM
Oct 31, 2018 08:00AM
Oct 19, 2018 07:50AM
Oct 19, 2018 07:50AM
Oct 15, 2018 09:11AM
Sep 26, 2018 08:00AM Ocular Therapeutix™ to Present at the 2018 Cantor Global Healthcare Conference
Aug 29, 2018 08:00AM

12,349 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All